Please provide your email address to receive an email when new articles are posted on . For the past two decades, significant progress in our understanding of the molecular basis of cancer has ...

The most commonly used treatments for metastatic renal cell carcinoma (RCC) have limited efficacy, considerable toxicity, and seldom benefit patients with poor prognosis. Early trials of temsirolimus ...

Learn everything you need to know about Temsirolimus-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

Temsirolimus was better tolerated than interferon. Fewer patients treated with temsirolimus had grade 3 or 4 (severe) side effects compared with those treated with interferon or the combination of ...

The role of the genomic breast cancer index in predicting pathologic complete response in breast cancer patients treated with neoadjuvant anthracycline plus taxane. Background: Hyperactivation of the ...

Interferon (IFN)-α is a widely used agent for the treatment of metastatic renal cell carcinoma (RCC), but it has limited efficacy and considerable toxicity. Temsirolimus, an inhibitor of mammalian ...

Interferon alfa is widely used for metastatic renal-cell carcinoma but has limited efficacy and tolerability. Temsirolimus, a specific inhibitor of the mammalian target of rapamycin kinase, may ...

June 29, 2007 (Chicago) -- Two new analyses of a phase 3 trial of temsirolimus ( Torisel, Wyeth) show the drug improves overall survival in patients with clear cell and other tumor cell types, and ...

Latent Epstein-Barr Virus Infection of Tumor Cells in Classical Hodgkin's Lymphoma Predicts Adverse Outcome in Older Adult Patients Here, we report the results of a randomized, open-label, phase III ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL® (temsirolimus) compared with bevacizumab plus ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability of Temsirolimus Injection in the United States. Fresenius Kabi’s Temsirolimus Injection is supplied as a ...

Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC) Pfizer Inc. announced today that the Phase 3 INTORACT trial ...